Pfizer and Merck have both developed antiviral pills that could help reduce the risk of hospitalization or death from COVID-19. Dr. Giridar Malyah, senior policy officer at the Robert Wood Johnson Foundation, joins CBSN to discuss the latest on the coronavirus pandemic.
